Aranidipine
From Self-sufficiency
Revision as of 14:28, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))
File:Aranidipine.svg | |
Systematic (IUPAC) name | |
---|---|
O5-methyl O3-(2-oxopropyl)
2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 86780-90-7 |
ATC code | none |
PubChem | CID 2225 |
Chemical data | |
Formula | C19H20N2O7 |
Molar mass | 388.37 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Aranidipine (INN, trade name Sapresta) is a calcium channel blocker.
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Calcium channel blockers
- Pyridines
- Carboxylate esters
- Ketones
- Nitro compounds
- Cardiovascular system drug stubs
- 2Fix